| Dec '18 | Sep '18 | Jun '18 | Mar '18 | Older periods | |
|---|---|---|---|---|---|
| (210.89%) | (143.16%) | (137.00%) | (76.37%) |
+8 more TTM periods Free account |
|
| (45.07%) | (49.13%) | (54.02%) | (32.19%) | ||
ROIC |
(73.72%) | (72.25%) | (103.89%) | (47.49%) | |
Return on Tangible Assets |
90.66% | 129.24% | 173.40% | 108.94% | |
Average Days of Receivables |
9.47 | 8.32 | 7.36 | 10.50 | |
Free Cash Flow per Share |
(1.61) | (0.57) | 0.24 | 0.31 | |
Free Cash Flow |
(44.99) | (15.91) | 6.61 | 8.59 | |
Capital Expenditures |
(33.76) | (30.78) | (25.01) | (18.97) | |
Piotroski F-Score |
2.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(5.04%) | 4.29% | 10.43% | 6.35% | |
Accounts Receivable Turnover |
38.74 | 43.21 | 48.59 | 35.28 | |
Accounts Payable Turnover |
9.32 | 16.30 | 12.17 | 8.53 | |
Inventory Turnover |
25.01 | 22.10 | 27.38 | 25.09 | |
Average Days of Payables |
39.37 | 23.34 | 37.53 | 48.74 | |
Days of Inventory on Hand |
15.17 | 16.33 | 13.32 | 14.79 | |
Tax Rate |
(0.08) | (0.15) | (0.16) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
34.49% | 34.53% | 34.37% | 34.31% | |
Share Based Compensation of Revenue |
1.45% | 1.51% | 1.01% | 1.07% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.05 | (0.05) | (0.08) | (0.11) | |
Depreciation/Fixed assets |
5.48 | 7.44 | 10.37 | 8.55 | |
Capex/Depreciation |
(0.15) | (0.09) | (0.05) | (0.06) | |
Revenue per Share |
36.26 | 37.11 | 38.06 | 39.18 | |
Operating CF per Share |
(0.40) | 0.53 | 1.14 | 0.99 | |
Capex per Share |
(1.21) | (1.09) | (0.90) | (0.68) | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | |
Net Profit Margin |
(22.16%) | (29.57%) | (35.65%) | (22.98%) |
Columns are period end dates